메뉴 건너뛰기




Volumn 369, Issue 9568, 2007, Pages 1144-1145

Pneumococcal vaccination and public health

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

EID: 34047272104     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60539-X     Document Type: Note
Times cited : (7)

References (7)
  • 1
    • 1442281111 scopus 로고    scopus 로고
    • Evidence-based public health: moving beyond randomized trials
    • Victora C., Habicht J., and Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health 94 (2004) 400-405
    • (2004) Am J Public Health , vol.94 , pp. 400-405
    • Victora, C.1    Habicht, J.2    Bryce, J.3
  • 2
    • 34047096257 scopus 로고    scopus 로고
    • Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
    • Grijalva C., Nuorti J., Arbogast P., Martin S., Edwards K., and Griffin M. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369 (2007) 1179-1186
    • (2007) Lancet , vol.369 , pp. 1179-1186
    • Grijalva, C.1    Nuorti, J.2    Arbogast, P.3    Martin, S.4    Edwards, K.5    Griffin, M.6
  • 3
    • 0242684416 scopus 로고    scopus 로고
    • Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    • for Active Bacterial Core Surveillance of the Emerging Infections Program Network
    • Whitney C., Farley M., Hadler J., and for Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
    • (2003) N Engl J Med , vol.348 , pp. 1737-1746
    • Whitney, C.1    Farley, M.2    Hadler, J.3
  • 4
    • 20144367956 scopus 로고    scopus 로고
    • Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    • for the Gambian Pneumococcal Vaccine Trial Group
    • Cutts F., Zaman S., Enwere G., and for the Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 (2005) 1139-1146
    • (2005) Lancet , vol.365 , pp. 1139-1146
    • Cutts, F.1    Zaman, S.2    Enwere, G.3
  • 5
    • 33847674917 scopus 로고    scopus 로고
    • World Health Organization definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines
    • Madhi S., and Klugman K. World Health Organization definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines. Vaccine 25 (2007) 2413-2419
    • (2007) Vaccine , vol.25 , pp. 2413-2419
    • Madhi, S.1    Klugman, K.2
  • 6
    • 24944542396 scopus 로고    scopus 로고
    • Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 893-897
    • (2005) MMWR Morb Mortal Wkly Rep , vol.54 , pp. 893-897
  • 7
    • 33744973294 scopus 로고    scopus 로고
    • Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects
    • Ray G., Whitney C., Fireman B., Ciuryla V., and Black S. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J 25 (2006) 494-501
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 494-501
    • Ray, G.1    Whitney, C.2    Fireman, B.3    Ciuryla, V.4    Black, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.